LAB logo

Standard BioTools (LAB)

Profile

Full Name

Standard BioTools Inc.

Ticker Symbol

LAB

Exchange

NASDAQ

Country

United States

IPO

February 10, 2011

Indexes

Not included

Employees

814

Key Details

Price

$1.16(+2.65%)

Market cap

$439.62M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$174.43M(+64.03% YoY)

Annual EPS

-$0.52(+44.68% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 27, 25 Keybanc
Sector Weight
Oct 31, 24 TD Cowen
Buy
Aug 1, 24 TD Cowen
Buy
Apr 16, 24 TD Cowen
Buy
Apr 4, 24 Jefferies
Buy
Jul 12, 23 Keybanc
Overweight
Aug 27, 20 UBS
Buy
Aug 10, 20 UBS
Buy
Nov 6, 19 Janney Montgomery Scott
Neutral
Oct 18, 19 UBS
Buy

Institutional Ownership

  • What is the ticker symbol for Standard BioTools?
  • Does Standard BioTools pay dividends?
  • What sector is Standard BioTools in?
  • What industry is Standard BioTools in?
  • What country is Standard BioTools based in?
  • When did Standard BioTools go public?
  • Is Standard BioTools in the S&P 500?
  • Is Standard BioTools in the NASDAQ 100?
  • Is Standard BioTools in the Dow Jones?
  • When was Standard BioTools's last earnings report?
  • When does Standard BioTools report earnings?
  • Should I buy Standard BioTools stock now?

What is the ticker symbol for Standard BioTools?

The ticker symbol for Standard BioTools is NASDAQ:LAB

Does Standard BioTools pay dividends?

No, Standard BioTools does not pay dividends

What sector is Standard BioTools in?

Standard BioTools is in the Healthcare sector

What industry is Standard BioTools in?

Standard BioTools is in the Medical Devices industry

What country is Standard BioTools based in?

Standard BioTools is headquartered in United States

When did Standard BioTools go public?

Standard BioTools's initial public offering (IPO) was on February 10, 2011

Is Standard BioTools in the S&P 500?

No, Standard BioTools is not included in the S&P 500 index

Is Standard BioTools in the NASDAQ 100?

No, Standard BioTools is not included in the NASDAQ 100 index

Is Standard BioTools in the Dow Jones?

No, Standard BioTools is not included in the Dow Jones index

When was Standard BioTools's last earnings report?

Standard BioTools's most recent earnings report was on Feb 26, 2025

When does Standard BioTools report earnings?

The next expected earnings date for Standard BioTools is May 8, 2025

Should I buy Standard BioTools stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page